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ABSTRACT 
Background; A substantial proportion of children will experience at least one episode with bronchiolitis, and as 
much as 2-3% of all children was hospitalized with bronchiolitis during their first year of life. Bronchiolitis is the 
most common reason for hospitalization of children in many countries, challenging both economy, area and 
staffing in paediatric departments. Objective; To Compare outcome of hypertonic saline versus normal saline in 
children with acute bronchiolitis.   Material and Methods; All children fulfilling inclusion criteria were 
registered in this study from Emergency Department of Pediatric Medicine, Nishtar Hospital, Multan. In Group 
A, each child was nebulized with 4 ml of 3 % of hypertonic saline while group B was nebulized with 4 ml of 
0.9% saline solution for 3 times at interval of 20 minutes. Results; Of these 302 study cases, 178 (58.9 %) were 
male patients while 124 (41.1 %) were female patients. Mean age of our study cases was 7.60 ± 6.19 months 
(ranging from 2 months to 24 months). Mean age of the male patients was noted to be 5.71 ± 3.22 months while 
that female patients was 10.32 ± 8.14 months (p=0.000). Mean baseline clinical severity score was 7.15 ± 1.63 
while 228 (75.5%) had baseline severity score up to 8. Of these 302 study cases, need for hospitalization was 
noted in 122 (40.4%). Need for hospitalization in group A was 41 (27.2%) while in group B it was 81 (53.6%). 
(p = 0.000). Conclusion; Our study results support the use hypertonic saline solution nebulization in children 
with acute bronchiolitis as compared with normal saline nebulization. Hypertonic solution was found to be more 
effective in improving clinical severity score and reducing need of hospitalization significantly. All clinicians 
treating such patients should employ hypertonic solution to get desired clinical outcomes.  
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INTRODUCTION; 
Acute bronchiolitis is a leading cause of hospitalization in infants and leads to at least one office visit in 
approximately 10% of children less than 2 years 1. Despite a lack of supporting evidence, many interventions 
continue to be used excessively, prompting efforts to curb unnecessary testing and treatments. While there have 
been some signs of success on reducing excessive care in bronchiolitis, substantial overuse and practice variation 
persist 2-4.  
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal DOI: 10.7176/JMPB 
Vol.54, 2019 
 
98 
In Pakistan, acute respiratory illness (ARI) is one of the leading causes of death in young children 
responsible for 20-30% of all child death under age 5 years. It occurs in a seasonal pattern, with peak incidence 
in the winter to spring months. Risk factors for early onset disease and subsequent hospitalization include low 
birth weight, prematurity, lower socioeconomic group, crowded living conditions, parental smoking, absence of 
breast-feeding, and day care centers. Majority of the children present with respiratory distress and wheezing5-8. 
  
Infants with bronchiolitis often undergo extensive and largely needless, diagnostic evaluation. The 2006 
American Academy of Pediatrics (AAP) bronchiolitis clinical practice guideline (CPG) recommended no routine 
laboratory or radiologic studies in bronchiolitis, but there is evidence that a substantial amount of testing is still 
performed. Bronchiolitis is usually a mild, self-limiting disease, but many children require hospitalisation, while 
1–2.7% need critical care support 9. Despite its high incidence and morbidity, there are few effective therapies 
for acute bronchiolitis in infancy, and the mainstay of treatment remains supportive care. Given the theoretical 
effects of hypertonic saline (HS) in reducing airway edema, unblocking mucus plugging, and improving 
mucociliary clearance, HS administered via nebulizer has been proposed as a potentially effective therapy for 
acute bronchiolitis in infants. The first randomized trial, published in 2002, the percentage decrease in the 
clinical score after inhalation therapy was significantly better for hypertonic nebulization (33%) than for normal 
saline nebulization (13%) [p < 0.005].10 
Over the past decades, a growing number of randomized trials have been undertaken to assess the 
effects and safety of nebulized HS in infants with acute bronchiolitis.11 A study conducted by Wu et al 12 reported 
28.9% hospitalization in children nebulized with hypertonic saline compared with 42.6 % with normal saline.  
 
MATERIAL AND METHODS; 
Patients with underlying broncho-pulmonary dysplasia, chronic lung diseases, neuromuscular impairment, 
immunodeficiency or congenital heart disease were excluded from our study. A specialized proforma has been 
developed to record the findings of this study. All children fulfilling inclusion criteria were registered in this 
study from Emergency Department of Pediatric Medicine, Nishtar Hospital, Multan. Prior permission was taken 
from Institutional Ethical Committee to conduct this study. Informed consent was taken from the parents of each 
child, describing them objectives of the study, ensuring them confidentiality of the information provided and fact 
that there is no risk involved to the patient while taking part in this study.  Baseline information like heart rate, 
respiratory rate, wheeze score and clinical severity score was taken. These study cases were randomly divided 
into 2 groups by draws methods. Parents were given sealed envelops marked with letters A and B, those who 
pick envelop marked with A, was placed in group A while those who pick envelop marked with B was placed in 
Group B. In Group A, each child was nebulized with 4 ml of 3 % of hypertonic saline while group B was 
nebulized with 4 ml of 0.9% saline solution for 3 times at interval of 20 minutes. The ED physicians prescribed 2 
additional treatments every 20 minutes to a maximum of 3 inhaled doses. Other care was provided per local 
clinical practice of hospital. Criteria for admission in these guidelines included a persistent oxygen saturation 
level of less than 92%, increased work of breathing, or inadequate oral intake 12.  All the data was entered and 
analyzed using SPSS-18. Descriptive statistics was applied to calculate mean and standard deviation for age of 
patients and duration of hospital stays. Frequencies and percentage were tabulated for the categorical variables 
like gender, residential status, family income, mother’s education, hospitalization and age groups. Chi – square 
test was applied to compare need for hospitalization in both groups. 
RESULTS; 
Our study comprised of a total of 302 patients meeting inclusion criteria of our study. Of these 302 study cases, 
178 (58.9 %) were male patients while 124 (41.1 %) were female patients. Mean age of our study cases was 7.60 
± 6.19 months (with minimum age of our study cases was 2 months while maximum age was 24 months). Mean 
age of the male patients was noted to be 5.71 ± 3.22 months while that female patients was 10.32 ± 8.14 months 
(p=0.000). Our study results have indicated that majority of our study cases i.e. 253 (83.8 %) were aged up to 12 
months. Of these 302 study cases, 82 (27.2 %) belonged to rural areas and 220 (72.8 %) belonged to urban areas. 
Monthly family income up to Rs. 35000 was noted in 105 (34.8%) while more than Rs. 35000 was noted in 197 
(65.2%) of our study cases. Of these 302 study cases, 139 (46.0%) mothers were illiterate while 163 (54.0%) 
were literate. Mean baseline clinical severity score was 7.15 ± 1.63 while after treatment it was 5.02 ± 3.01, 
mean clinical severity score after treatment in group A was 4.18 ± 2.91 whereas in group B was 5.87 ± 2.87 (p = 
0.001).  Of these 302 study cases, 228 (75.5%) had baseline severity score up to 8.  Of these 302 study cases, 
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need for hospitalization was noted in 122 (40.4%). Need for hospitalization in group A was 41 (27.2%) while in 
group B it was 81 (53.6%). (p = 0.000).  
DISCUSSION;  
Our study comprised of a total of 302 patients meeting inclusion criteria of our study. Of these 302 
study cases, 178 (58.9 %) were male patients while 124 (41.1 %) were female patients. Different studies have 
documented male gender predominance in patients with acute bronchiolitis. A study conducted by Arif et al 13 
from Lahore reported 68 % boys with acute bronchiolitis which is similar to our study results. Another study 
from Faisalabad by Ahmed et al 14 reported 1.4:1 male to female ratio which is showing male gender 
predominance. These findings of Ahmed et al 14 are in compliance with that of our study results. Jacobs et al 15 
reported 69 % boys with acute bronchiolitis showing male gender predominance which is in compliance with our 
findings. However Naz et al 6 from Lahore reported 40 % boys with acute bronchiolitis and 60 % girls which is 
quite different from our study results.  
Mean age of our study cases was 7.60 ± 6.19 months (with minimum age of our study cases was 2 
months while maximum age was 24 months). Mean age of the male patients was noted to be 5.71 ± 3.22 months 
while that female patients was 10.32 ± 8.14 months (p=0.000). Our study results have indicated that majority of 
our study cases i.e. 253 (83.8 %) were aged up to 12 months. Airf et al 13 from Lahore reported 5.43 ± 9.44 
months mean age of the children with acute bronchiolitis which is close to our study results. Ahmed et al 14 from 
Faisalabad reported 7.6 ± 4.7 months mean age which is close to our study results. Jacobs et al 15 reported 6.0 ± 
3.9 months mean age which is similar to our study results. Naz et al 6 reported 3 months mean age which is a bit 
lower than that of our study results.  
Of these 302 study cases, 82 (27.2 %) belonged to rural areas and 220 (72.8 %) belonged to urban areas. 
Monthly family income up to Rs. 35000 was noted in 105 (34.8%) while more than Rs. 35000 was noted in 197 
(65.2%) of our study cases. Of these 302 study cases, 139 (46.0%) mothers were illiterate while 163 (54.0%) 
were literate. Similar findings have been reported by Ahmed et al 14 from Faisalabad.  
Mean baseline clinical severity score was 7.15 ± 1.63 while after treatment it was 5.02 ± 3.01, mean clinical 
severity score after treatment in group A was 4.18 ± 2.91 whereas in group B was 5.87 ± 2.87 (p = 0.001).  Of 
these 302 study cases, 228 (75.5%) had baseline severity score up to 8. A study conducted in Lahore by Ejaz et 
al 16 reported 5.68 ± 0.73 clinical severity score which is in compliance with our study results. Jacobs et al 15 
reported 5.7 ± 1.8 mean score which is similar to that of our study results. 
Of these 302 study cases, need for hospitalization was noted in 122 (40.4%). Need for hospitalization in group A 
was 41 (27.2%) while in group B it was 81 (53.6%). (p = 0.000).  A study conducted by Wu et al 12 reported 
28.9% hospitalization in children nebulized with hypertonic saline compared with 42.6 % with normal saline. 
These findings are close to our study results.  
CONCLUSION; 
Our study results support the use hypertonic saline solution nebulization in children with acute 
bronchiolitis as compared with normal saline nebulization. Hypertonic solution was found to be more effective 
in improving clinical severity score and reducing need of hospitalization significantly. Its use was safe, reliable 
and no adverse side effects were noted. All clinicians treating such patients should employ hypertonic solution to 
achieve desired clinical outcomes.  
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